Home » Stocks » Zosano Pharma

Zosano Pharma Corporation (ZSAN)

Stock Price: $1.64 USD 0.28 (20.59%)
Updated Aug 14, 2020 4:00 PM EDT - Market closed
After-hours: $1.65 +0.01 (0.61%) Aug 14, 7:59 PM

Stock Price Chart

Key Info

Market Cap 112.48M
Revenue (ttm) n/a
Net Income (ttm) -35.39M
Shares Out 54.36M
EPS (ttm) -1.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 14, 2020
Last Price $1.64
Previous Close $1.36
Change ($) 0.28
Change (%) 20.59%
Day's Open 1.36
Day's Range 1.35 - 1.75
Day's Volume 13,827,436
52-Week Range 0.41 - 3.21

More Stats

Market Cap 112.48M
Enterprise Value 119.21M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 54.36M
Float 68.46M
EPS (basic) -1.38
EPS (diluted) -1.11
FCF / Share -0.78
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5.68M
Short Ratio 1.98
Short % of Float 11.01%
Beta 2.71
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 3.54
Revenue n/a
Operating Income -34.60M
Net Income -35.39M
Free Cash Flow -42.90M
Net Cash -6.73M
Net Cash / Share -0.10
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -46.25%
ROE -188.88%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(164.02% upside)
Current: $1.64
Target: 4.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-----89.06%-32.68%-
Gross Profit----0.312.764.25
Operating Income-37.20-35.38-28.37-28.63-26.37-12.61-7.97
Net Income-37.59-35.36-29.11-29.83-28.43-14.24-5.61
Shares Outstanding16.389.451.730.690.570.260.26
Earnings Per Share-2.29-3.74-16.82-43.36-49.80-55.60-22.00
Operating Cash Flow-34.82-29.12-26.84-25.69-24.16-10.92-3.72
Capital Expenditures-11.76-5.48-1.22-0.22-0.43-1.18-0.90
Free Cash Flow-46.58-34.60-28.06-25.91-24.59-12.09-4.62
Cash & Equivalents6.7723.4612.1115.0436.971.255.98
Total Debt17.726.836.6912.5415.2722.0613.32
Net Cash / Debt-10.9516.635.422.5021.70-20.81-7.34
Book Value9.3918.717.054.4926.50-13.400.48
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zosano Pharma Corporation
Country United States
Employees 56
CEO Steven Lo

Stock Information

Ticker Symbol ZSAN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ZSAN
IPO Date January 27, 2015


Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.